71 related articles for article (PubMed ID: 15559961)
1. MRI in breast cancer.
Gur D
N Engl J Med; 2004 Nov; 351(21):2235-6; author reply 2235-6. PubMed ID: 15559961
[No Abstract] [Full Text] [Related]
2. Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?
Houssami N; Wilson R
Breast; 2007 Feb; 16(1):2-4. PubMed ID: 17189696
[No Abstract] [Full Text] [Related]
3. Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.
Essink-Bot ML; Rijnsburger AJ; van Dooren S; de Koning HJ; Seynaeve C
Breast; 2006 Oct; 15(5):673-6. PubMed ID: 16556497
[TBL] [Abstract][Full Text] [Related]
4. MRI in breast cancer management: potential for benefit and harm.
Jatoi I
Int J Fertil Womens Med; 2005; 50(6):281-4. PubMed ID: 16526420
[TBL] [Abstract][Full Text] [Related]
5. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
[TBL] [Abstract][Full Text] [Related]
7. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
[TBL] [Abstract][Full Text] [Related]
8. [MRI for breast disease diagnosis; an asset, but the proper place has to be determined first].
Wobbes T
Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1490-2. PubMed ID: 16032991
[TBL] [Abstract][Full Text] [Related]
9. MRI in breast cancer.
Altundag K; Morandi P; Altundag O
N Engl J Med; 2004 Nov; 351(21):2235-6; author reply 2235-6. PubMed ID: 15548786
[No Abstract] [Full Text] [Related]
10. [Feasibility of MRI imaging in patients with breast cancer].
Mooyaart EA; Veltman J; Boetes C; Blickman JG
Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1521-7. PubMed ID: 16032998
[TBL] [Abstract][Full Text] [Related]
11. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
12. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
13. Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery.
Howarth D; Slater S; Lau P; Booker J; Clark D; Sillar R
Australas Radiol; 2005 Aug; 49(4):289-97. PubMed ID: 16026435
[TBL] [Abstract][Full Text] [Related]
14. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
Wright H; Listinsky J; Rim A; Chellman-Jeffers M; Patrick R; Rybicki L; Kim J; Crowe J
Am J Surg; 2005 Oct; 190(4):572-5. PubMed ID: 16164923
[TBL] [Abstract][Full Text] [Related]
16. Screening for hereditary breast cancer.
Dent R; Warner E
Semin Oncol; 2007 Oct; 34(5):392-400. PubMed ID: 17920893
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Hagen AI; Kvistad KA; Maehle L; Holmen MM; Aase H; Styr B; Vabø A; Apold J; Skaane P; Møller P
Breast; 2007 Aug; 16(4):367-74. PubMed ID: 17317184
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging.
Samphao S; Wheeler AJ; Rafferty E; Michaelson JS; Specht MC; Gadd MA; Hughes KS; Smith BL
Am J Surg; 2009 Oct; 198(4):538-43. PubMed ID: 19800464
[TBL] [Abstract][Full Text] [Related]
19. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
Warner E
Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
[TBL] [Abstract][Full Text] [Related]
20. [MRI-guided biopsy of the breast: new possibilities but also new problems].
Wobbes T
Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1756-7. PubMed ID: 16948233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
